DaratumumabVarious toxicities and off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1965卷 / 1期

关键词：

D O I：

10.1007/s40278-023-43142-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：174 / 174

相关论文

共 50 条

[1] PrednisoloneVarious toxicities and off-label use: case report
Reactions Weekly, 2023, 1945 (1) : 452 - 452
[2] AntineoplasticsVarious toxicities and off-label use : case report
Reactions Weekly, 2024, 2027 (1) : 58 - 58
[3] ImmunosuppressantsVarious toxicities and off-label use: case report
Reactions Weekly, 2022, 1898 (1) : 225 - 225
[4] ImatinibVarious toxicities and off-label use: case report
Reactions Weekly, 2023, 1945 (1) : 279 - 279
[5] DexamethasoneVarious toxicities and off-label use: case report
Reactions Weekly, 2022, 1904 (1) : 181 - 181
[6] Multiple drugsVarious toxicities, off-label use and no response to off-label therapy: case report
Reactions Weekly, 2021, 1861 (1) : 232 - 232
[7] Axitinib/nivolumabVarious toxicities and off-label use: case report
Reactions Weekly, 2022, 1904 (1) : 89 - 89
[8] AntineoplasticsVarious toxicities, off-label use and no response: case report
Reactions Weekly, 2021, 1857 (1) : 49 - 49
[9] MethotrexateVarious toxicities following off-label use: case report
Reactions Weekly, 2021, 1839 (1) : 188 - 188
[10] SorafenibVarious toxicities following off-label use: case report
Reactions Weekly, 2019, 1766 (1) : 270 - 270

← 1 2 3 4 5 →